CASI News and Press, CASI Pharmaceuticals Inc. From 03/07/19

ROCKVILLE, Md. , March 7, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. based pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China , U.S., and throughout the world, a...

ROCKVILLE, Md. , Feb. 19, 2019 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. based pharmaceutical company with a platform to develop and accelerate the launch of pharmaceutical products and innovative therapeutics in China , U.S., and throughout the world, today ...

The following slide deck was published by CASI Pharmaceuticals in conjunction with this Read more ...

CORAL GABLES, FL / ACCESSWIRE / December 28, 2018 / The healthcare industry has shown tremendous growth over the last few months, as experts and professionals in the field have worked on developing technologies to improve the quality of care for patients on a global scale. From data-based ...

Deals and Financings WuXi AppTec (SHA: 603259), China's largest CRO/CMO, completed a $1 billion IPO on the Hong Kong markets, pricing the offering in the middle of the expected range. In May, WuXi became a public company by completing a $328 million IPO in Shanghai. Since the offering, the...

CASI Pharmaceuticals (NASDAQ: CASI ) has received National Medical Products Administration ("NMPA") approval of Melphalan Hydrochloride For Injection (EVOMELA®), for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patient...

ROCKVILLE, Md. , Dec. 3, 2018 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to patients in China and throughout the...

Gainers: Red Hat (NYSE: RHT ) +45% . Diana Containerships (NASDAQ: DCIX ) +24%  CASI Pharmaceuticals (NASDAQ: CASI ) +21% . Evogene (NYSE: EVGN ) +19%  Cooper Tire & Rubber Company (NYSE: CTB ) +18% . LM Funding America (NASDAQ: LMFA ) +17% . Stoneridge (NYSE: SRI ) +...

Deals and Financings Innovent Biologics has priced its Hong Kong IPO to raise $421 million, very close to the top of the expected range. The company set its offering price at HK$13.98, just below the top of the range. The successful IPO shows investors are still interested in young China bio...